trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7 Mama >98.0% (HPLC) Afatinib Dimaleate Intermediate
Ruifu Sapalai Vailaau Fa'alava ole Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-tasi CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl) oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl) oxy)quinazolin-4-AmineCAS 314771-88-5
Igoa Vailaau | trans-4-Dimethylaminocrotonic Acid Hydrochloride |
Synonyms | trans 4-Dimethylaminocrotonic Acid HCl;(E)-4-(Dimethylamino)-2-Butenoic Acid Hydrochloride;(E)-4-Dimethylaminocrotonic Acid Hydrochloride;(2E)-4-(Dimethylamino)ae-2-Enoic Acid Hydrochloride;Afatinib int-2 |
Numera CAS | 848133-35-7 |
Tulaga Fa'asoa | I Fa'atauga, Fua Fa'atau |
Fuafua mole | C6H12ClNO2 |
Molecular Weight | 165.62 |
Ma'ale'ale | Hygroscopic.Susū ma'ale'ale |
Lisi Lisi | 160.0 i le 164.0 ℃ |
Solubility | DMSO (Teisi), Methanol (Teisi), Suavai (Teisi) |
COA & MSDS | Avanoa |
Amataga | Shanghai, Saina |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e ile Toeitiiti Pa'epa'e Pa'u |
Mama / Suʻesuʻega Metotia | >98.0% (HPLC) |
Mama / Suʻesuʻega Metotia | >98.0% (NMR) |
Susū (KF) | <0.50% |
Toega i luga o le mumu | <0.20% |
Le mama nofofua | <0.50% |
Metala mamafa (pei o le Pb) | <20ppm |
Alaleo Infrared | E tusa ma le Fauga |
1 H NMR Alaleo | Proton NMR Alaleo |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Intermediate of Afatinib, Afatinib Dimaleate |
afifi:Fagu, Ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau.
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu.
Va'a:Tu'u atu ile lalolagi atoa ile ea, ile FedEx / DHL Express.Tuuina atu vave ma faatuatuaina tiliva.
Meafaigaluega: Agilent 1200 HPLC HPLC chromatograph, DAD detector.
Koluma: Agilent XDB-C18,250*4.6mm, 5μm
Vaega feavea'i: B: 1.95g sodium octane sulfonate + 8ml phosphoric acid + 5ml triethylamine + 500ml vai
C: acetonitrile
Sauniuniga ole vaega fefiloi fefiloi: ave le 400ml B solution ma le 100ml acetonitrile, faʻafefiloi lelei ma tutusa, ma pamu le vai i le tasi vaega.
Fuafuaga tafe: 0.5ml/min54bar
Koluma vevela: 25℃
Umi ole galu: 210nm
Faʻataʻitaʻiga fofo: faʻaogaina le vaega feaveaʻi e pei o le solvent, faʻataʻitaʻiga malosi: 0.0040g / 2ml, faʻataʻitaʻiga tele 2.0μl.
trans-4-Dimethylaminocrotonic Acid Hydrochloride (CAS: 848133-35-7) o se reagent faʻaaogaina i le sauniuniga o le tyrosine kinase faʻalavelave faʻamaʻi faʻamaʻi.trans-4-Dimethylaminocrotonic Acid Hydrochloride e mafai ona faʻaaogaina e avea o se vaeluaga o Afatinib (CAS: 439081-18-2), Afatinib Dimaleate (CAS: 850140-73-7), Neratinib (CAS: 698387-09-6).Afatinib o se vailaʻau faʻamaonia mo le togafitiga e le o ni tamaʻi sela mama mama (NSCLC), na atiaʻe e Boehringer Ingelheim.E galue o se inhibitor angiokinase.E pei o Lapatinib ma Neratinib, o le Afatinib o le tyrosine kinase inhibitor (TKI) lea e le mafai foi ona faʻalavelaveina le tagata epidermal growth factor receptor 2 (Her2) ma le epidermal growth factor receptor (EGFR) kinases.Afatinib e le gata o loʻo galue faasaga i le EGFRsuiga o lo'o fa'atatau ile tupulaga muamua TKI e pei o le gefitinib po'o le gefitinib, ae fa'asaga ia i latou e le maaleale i nei togafitiga masani.Ona o lana gaioiga faaopoopo faasaga ia Her2, o loʻo suʻesuʻeina mo le kanesa o le susu faʻapea foʻi ma isi faʻamaʻi EGFR ma Her2.Neratinib na atiaʻe e le US Wyeth kamupani o se mea e le mafai ona faʻaaogaina epidermal growth factor receptor (EGFR) inhibitor.Ose vaega fa'atatau e tele o tama'i molecule tyrosine kinase inhibitors i le HER 2 ma le HER1 pe a uma Lapatinib, ma o se ErbB receptor tyrosine kinase inhibitor e le mafai ona fa'afoliga.Neratinib e mafai ona filifili fa'alavelave HER-1 ma HER-2 ole aiga EGFR (IC50 e 92 nmol/L ma le 59 nmol/L, fa'asologa).O su'esu'ega fa'afoma'i na fa'aalia ai o le Neratinib na fa'atinoina le tele o le fa'amalologa i le kanesa o le mama e le o ni sela laiti, kanesa colon, ma le kanesa o le susu.O le faʻataʻitaʻiga faʻataʻitaʻi faʻataʻitaʻi faʻataʻitaʻiga na faʻaalia ai o le Neratinib na faʻaalia le lelei ma le faʻapalepale i tagata mamaʻi HER-2 maʻi maʻi maʻi maualuga le kanesa o le susu na maua pe leai foi Trastuzumab togafitiga.O le vaega Ⅲ fa'ata'ita'iga o le kanesa o le susu na mae'a ia Setema 2014.